Vitamin C and cancer risk and treatment

[1] Maggini S., Wintergerst E.S., Beveridge S., Hornig D.H.: Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br. J. Nutr., 2007; 98: S29–S35. Maggini S. Wintergerst E.S. Beveridge S. Hornig D.H. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses Br. J. Nutr. 2007 98 S29 S35 10.1017/S0007114507832971 Search in Google Scholar

[2] Padayatty S.J., Levine M.: Vitamin C: The known and the unknown and goldilocks. Oral Dis., 2016; 22: 463–493. Padayatty S.J. Levine M. Vitamin C: The known and the unknown and goldilocks Oral Dis. 2016 22 463 493 10.1111/odi.12446 Search in Google Scholar

[3] Smirnoff N., Wheeler G.L.: Ascorbic acid in plants: Biosynthesis and function. Crit. Rev. Biochem. Mol. Biol., 2000; 35: 291–314. Smirnoff N. Wheeler G.L. Ascorbic acid in plants: Biosynthesis and function Crit. Rev. Biochem. Mol. Biol. 2000 35 291 314 10.1080/10409230008984166 Search in Google Scholar

[4] Vissers M.C., Das A.B.: Potential mechanisms of action for vitamin C in cancer: Reviewing the evidence. Front Physiol., 2018; 9: 809. Vissers M.C. Das A.B. Potential mechanisms of action for vitamin C in cancer: Reviewing the evidence Front Physiol. 2018 9 809 10.3389/fphys.2018.00809 Search in Google Scholar

[5] González M.J., Miranda-Massari J.R., Mora E.M., Guzmán A., Riordan N.H., Riordan H.D., Casciari J.J., Jackson J.A., Román-Franco A.: Orthomolecular oncology review: Ascorbic acid and cancer 25 years later. Integr. Cancer Ther., 2005; 4: 32–44. González M.J. Miranda-Massari J.R. Mora E.M. Guzmán A. Riordan N.H. Riordan H.D. Casciari J.J. Jackson J.A. Román-Franco A. Orthomolecular oncology review: Ascorbic acid and cancer 25 years later Integr. Cancer Ther. 2005 4 32 44 10.1177/1534735404273861 Search in Google Scholar

[6] Blaszczak W., Barczak W., Masternak J., Kopczyński P., Zhitkovich A., Rubiś B.: Vitamin C as a modulator of the response to cancer therapy. Molecules, 2019; 24: 453. Blaszczak W. Barczak W. Masternak J. Kopczyński P. Zhitkovich A. Rubiś B. Vitamin C as a modulator of the response to cancer therapy Molecules 2019 24 453 10.3390/molecules24030453 Search in Google Scholar

[7] Klimant E., Wright H., Rubin D., Seely D., Markman M.: Intravenous vitamin C in the supportive care of cancer patients: A review and rational approach. Curr. Oncol., 2018; 25: 139–148. Klimant E. Wright H. Rubin D. Seely D. Markman M. Intravenous vitamin C in the supportive care of cancer patients: A review and rational approach Curr. Oncol. 2018 25 139 148 10.3747/co.25.3790 Search in Google Scholar

[8] Monti D.A., Mitchell E., Bazzan A.J., Littman S., Zabrecky G., Yeo C.J., Pillai M.V., Newberg A.B., Deshmukh S., Levine M.: Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One, 2012; 7: e29794. Monti D.A. Mitchell E. Bazzan A.J. Littman S. Zabrecky G. Yeo C.J. Pillai M.V. Newberg A.B. Deshmukh S. Levine M. Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer PLoS One 2012 7 e29794 10.1371/journal.pone.0029794 Search in Google Scholar

[9] Wang H., Dutta B., Huang W., Devoe L.D., Leibach F.H., Ganapathy V., Prasad P.D.: Human Na⁺-dependent vitamin C transporter 1 (hSVCT1): Primary structure, functional characteristics and evidence for a non-functional splice variant. Biochim. Biophys. Acta, 1999; 1461: 1–9. Wang H. Dutta B. Huang W. Devoe L.D. Leibach F.H. Ganapathy V. Prasad P.D. Human Na⁺-dependent vitamin C transporter 1 (hSVCT1): Primary structure, functional characteristics and evidence for a non-functional splice variant Biochim. Biophys. Acta 1999 1461 1 9 10.1016/S0005-2736(99)00182-0 Search in Google Scholar

[10] Bánhegyi G., Benedetti A., Margittai E., Marcolongo P., Fulceri R., Németh C.E., Szarka A.: Subcellular compartmentation of ascorbate and its variation in disease states. Biochim. Biophys. Acta, 2014; 1843: 1909–1916. Bánhegyi G. Benedetti A. Margittai E. Marcolongo P. Fulceri R. Németh C.E. Szarka A. Subcellular compartmentation of ascorbate and its variation in disease states Biochim. Biophys. Acta 2014 1843 1909 1916 10.1016/j.bbamcr.2014.05.01624907663 Search in Google Scholar

[11] Cantuaria G., Fagotti A., Ferrandina G., Magalhaes A., Nadji M., Angioli R., Penalver M., Mancuso S., Scambia G.: GLUT-1 expression in ovarian carcinoma: Association with survival and response to chemotherapy. Cancer, 2001; 92: 1144–1150. Cantuaria G. Fagotti A. Ferrandina G. Magalhaes A. Nadji M. Angioli R. Penalver M. Mancuso S. Scambia G. GLUT-1 expression in ovarian carcinoma: Association with survival and response to chemotherapy Cancer 2001 92 1144 1150 10.1002/1097-0142(20010901)92:5<1144::AID-CNCR1432>3.0.CO;2-T Search in Google Scholar

[12] Yun J., Mullarky E., Lu C., Bosch K.N., Kavalier A., Rivera K., Roper J., Chio I.I., Giannopoulou E.G., Rago C., et al.: Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science, 2015; 350: 1391–1396. Yun J. Mullarky E. Lu C. Bosch K.N. Kavalier A. Rivera K. Roper J. Chio I.I. Giannopoulou E.G. Rago C. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH Science 2015 350 1391 1396 10.1126/science.aaa5004 Search in Google Scholar

[13] Lv H., Wang C., Fang T., Li T., Lv G., Han Q., Yang W., Wang H.: Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2. NPJ Precis. Oncol., 2018; 2: 1. Lv H. Wang C. Fang T. Li T. Lv G. Han Q. Yang W. Wang H. Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2 NPJ Precis. Oncol. 2018 2 1 10.1038/s41698-017-0044-8 Search in Google Scholar

[14] Chong T.L., Ahearn E.L., Cimmino L.: Reprogramming the epigenome with vitamin C. Front. Cell Dev. Biol., 2019; 7: 128. Chong T.L. Ahearn E.L. Cimmino L. Reprogramming the epigenome with vitamin C Front. Cell Dev. Biol. 2019 7 128 10.3389/fcell.2019.00128 Search in Google Scholar

[15] Howe G.R., Hirohata T., Hislop T.G., Iscovich J.M., Yuan J.M., Katsouyanni K., Lubin F., Marubini E., Modan B., Rohan T., et al.: Dietary factors and risk of breast cancer: Combined analysis of 12 case–control studies. J. Natl. Cancer Inst., 1990; 82: 561–569. Howe G.R. Hirohata T. Hislop T.G. Iscovich J.M. Yuan J.M. Katsouyanni K. Lubin F. Marubini E. Modan B. Rohan T. Dietary factors and risk of breast cancer: Combined analysis of 12 case–control studies J. Natl. Cancer Inst. 1990 82 561 569 10.1093/jnci/82.7.561 Search in Google Scholar

[16] Block G.: Vitamin C and cancer prevention: The epidemiologic evidence. Am. J. Clin. Nutr., 1991; 53: 270S–282S. Block G. Vitamin C and cancer prevention: The epidemiologic evidence Am. J. Clin. Nutr. 1991 53 270S 282S 10.1093/ajcn/53.1.270S Search in Google Scholar

[17] Xi D.: Vitamin C in cancer therapeutics and metastasis. J. Orthop. Res. Ther., 2019; 10: 1127. Xi D. Vitamin C in cancer therapeutics and metastasis J. Orthop. Res. Ther. 2019 10 1127 Search in Google Scholar

[18] Notani P.N., Jayant K.: Role of diet in upper aerodigestive tract cancers. Nutr. Cancer, 1987; 10: 103–113. Notani P.N. Jayant K. Role of diet in upper aerodigestive tract cancers Nutr. Cancer 1987 10 103 113 10.1080/01635588709513945 Search in Google Scholar

[19] Bo Y., Lu Y., Zhao Y., Zhao E., Yuan L., Lu W., Cui L., Lu Q.: Association between dietary vitamin C intake and risk of esophageal cancer: A dose-response meta-analysis. Int. J. Cancer, 2016; 138: 1843–1850. Bo Y. Lu Y. Zhao Y. Zhao E. Yuan L. Lu W. Cui L. Lu Q. Association between dietary vitamin C intake and risk of esophageal cancer: A dose-response meta-analysis Int. J. Cancer 2016 138 1843 1850 10.1002/ijc.29838 Search in Google Scholar

[20] Fontham E.T., Pickle L.W., Haenszel W., Correa P., Lin Y.P., Falk R.T.: Dietary vitamins A and C and lung cancer risk in Louisiana. Cancer, 1988; 62: 2267–2273. Fontham E.T. Pickle L.W. Haenszel W. Correa P. Lin Y.P. Falk R.T. Dietary vitamins A and C and lung cancer risk in Louisiana Cancer 1988 62 2267 2273 10.1002/1097-0142(19881115)62:10<2267::AID-CNCR2820621033>3.0.CO;2-E Search in Google Scholar

[21] Hua Y.F., Wang G.Q., Jiang W., Huang J., Chen G.C., Lu C.D.: Vitamin C intake and pancreatic cancer risk: A meta-analysis of published case-control and cohort studies. PLoS One, 2016; 11: e0148816. Hua Y.F. Wang G.Q. Jiang W. Huang J. Chen G.C. Lu C.D. Vitamin C intake and pancreatic cancer risk: A meta-analysis of published case-control and cohort studies PLoS One 2016 11 e0148816 10.1371/journal.pone.0148816 Search in Google Scholar

[22] Lin P.H., Aronson W., Freedland S.J.: An update of research evidence on nutrition and prostate cancer. Urol. Oncol., 2019; 37: 387–401. Lin P.H. Aronson W. Freedland S.J. An update of research evidence on nutrition and prostate cancer Urol. Oncol. 2019 37 387 401 10.1016/j.urolonc.2017.10.006 Search in Google Scholar

[23] Hoang B.V., Lee J., Choi I.J., Kim Y.W., Ryu K.W., Kim J.: Effect of dietary vitamin C on gastric cancer risk in the Korean population. World J. Gastroenterol., 2016; 22: 6257–6267. Hoang B.V. Lee J. Choi I.J. Kim Y.W. Ryu K.W. Kim J. Effect of dietary vitamin C on gastric cancer risk in the Korean population World J. Gastroenterol. 2016 22 6257 6267 10.3748/wjg.v22.i27.6257 Search in Google Scholar

[24] Myung S.K., Ju W., Kim S.C., Kim H., Korean Meta-analysis (KORMA) Study Group: Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: A meta-analysis. BJOG, 2011; 118: 1285–1291. Myung S.K. Ju W. Kim S.C. Kim H. Korean Meta-analysis (KORMA) Study Group Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: A meta-analysis BJOG 2011 118 1285 1291 10.1111/j.1471-0528.2011.03032.x Search in Google Scholar

[25] Bai X.Y., Qu X., Jiang X., Xu Z., Yang Y., Su Q., Wang M., Wu H.: Association between dietary vitamin C intake and risk of prostate cancer: A meta–analysis involving 103,658 subjects. J. Cancer, 2015; 6: 913–921. Bai X.Y. Qu X. Jiang X. Xu Z. Yang Y. Su Q. Wang M. Wu H. Association between dietary vitamin C intake and risk of prostate cancer: A meta–analysis involving 103,658 subjects J. Cancer 2015 6 913 921 10.7150/jca.12162 Search in Google Scholar

[26] Zhang S., Hunter D.J., Forman M.R., Rosner B.A., Speizer F.E., Colditz G.A., Manson J.E., Hankinson S.E., Willett W.C.: Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J. Natl. Cancer Inst., 1999; 91: 547–556. Zhang S. Hunter D.J. Forman M.R. Rosner B.A. Speizer F.E. Colditz G.A. Manson J.E. Hankinson S.E. Willett W.C. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer J. Natl. Cancer Inst. 1999 91 547 556 10.1093/jnci/91.6.547 Search in Google Scholar

[27] Fulan H., Changxing J., Baina W.Y., Wencui Z., Chunqing L., Fan W., Dandan L., Dianjun S., Tong W., Da P., Yashuang Z.: Retinol, vitamins A, C, and E and breast cancer risk: A meta-analysis and meta-regression. Cancer Causes Control, 2011; 22: 1383–1396. Fulan H. Changxing J. Baina W.Y. Wencui Z. Chunqing L. Fan W. Dandan L. Dianjun S. Tong W. Da P. Yashuang Z. Retinol, vitamins A, C, and E and breast cancer risk: A meta-analysis and meta-regression Cancer Causes Control 2011 22 1383 1396 10.1007/s10552-011-9811-y Search in Google Scholar

[28] Cui Y., Shikany J.M., Liu S., Shagufta Y., Rohan T.E.: Selected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the Women’s Health Initiative Observational Study. Am. J. Clin. Nutr., 2008; 87: 1009-1018. Cui Y. Shikany J.M. Liu S. Shagufta Y. Rohan T.E. Selected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the Women’s Health Initiative Observational Study Am. J. Clin. Nutr. 2008 87 1009 1018 10.1093/ajcn/87.4.1009 Search in Google Scholar

[29] Eichholzer M., Stähelin H.B., Gey K.F., Lüdin E., Bernasconi F.: Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int. J. Cancer, 1996; 66: 145–150. Eichholzer M. Stähelin H.B. Gey K.F. Lüdin E. Bernasconi F. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study Int. J. Cancer 1996 66 145 150 10.1002/(SICI)1097-0215(19960410)66:2<145::AID-IJC1>3.0.CO;2-2 Search in Google Scholar

[30] Loria C.M., Klag M.J., Caulfield L.E., Whelton P.K.: Vitamin C status and mortality in US adults. Am. J. Clin. Nutr., 2000; 72: 139–145. Loria C.M. Klag M.J. Caulfield L.E. Whelton P.K. Vitamin C status and mortality in US adults Am. J. Clin. Nutr. 2000 72 139 145 10.1093/ajcn/72.1.139 Search in Google Scholar

[31] Lin J., Cook N.R., Albert C., Zaharris E., Gaziano J.M., Van Denburgh M., Buring J.E., Manson J.E.: Vitamins C and E and beta carotene supplementation and cancer risk: A randomized controlled trial. J. Natl. Cancer Inst., 2009; 101: 14–23. Lin J. Cook N.R. Albert C. Zaharris E. Gaziano J.M. Van Denburgh M. Buring J.E. Manson J.E. Vitamins C and E and beta carotene supplementation and cancer risk: A randomized controlled trial J. Natl. Cancer Inst. 2009 101 14 23 10.1093/jnci/djn438 Search in Google Scholar

[32] Myung S.K., Kim Y., Ju W., Choi H.J., Bae W.K.: Effects of antioxidant supplements on cancer prevention: Meta-analysis of randomized controlled trials. Ann. Oncol., 2010; 21: 166–179. Myung S.K. Kim Y. Ju W. Choi H.J. Bae W.K. Effects of antioxidant supplements on cancer prevention: Meta-analysis of randomized controlled trials Ann. Oncol. 2010 21 166 179 10.1093/annonc/mdp286 Search in Google Scholar

[33] Park S.J., Myung S.K., Lee Y., Lee Y.J.: Effects of vitamin and antioxidant supplements in prevention of bladder cancer: A meta-analysis of randomized controlled trials. J. Korean Med. Sci., 2017; 32: 628–635. Park S.J. Myung S.K. Lee Y. Lee Y.J. Effects of vitamin and antioxidant supplements in prevention of bladder cancer: A meta-analysis of randomized controlled trials J. Korean Med. Sci. 2017 32 628 635 10.3346/jkms.2017.32.4.628 Search in Google Scholar

[34] Jiang L., Yang K.H., Tian J.H., Guan Q.L., Yao N., Cao N., Mi D.H., Wu J., Ma B., Yang S.H.: Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: A meta-analysis of randomized controlled trials. Nutr. Cancer, 2010; 62: 719–727. Jiang L. Yang K.H. Tian J.H. Guan Q.L. Yao N. Cao N. Mi D.H. Wu J. Ma B. Yang S.H. Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: A meta-analysis of randomized controlled trials Nutr. Cancer 2010 62 719 727 10.1080/01635581.2010.494335 Search in Google Scholar

[35] Myung S.K., Yang H.J.: Efficacy of vitamin and antioxidant supplements in prevention of esophageal cancer: Meta-analysis of randomized controlled trials. J. Cancer Prev., 2013; 18: 135–143. Myung S.K. Yang H.J. Efficacy of vitamin and antioxidant supplements in prevention of esophageal cancer: Meta-analysis of randomized controlled trials J. Cancer Prev. 2013 18 135 143 10.15430/JCP.2013.18.2.135 Search in Google Scholar

[36] Pais R.; Dumitraşcu D.L.: Do antioxidants prevent colorectal cancer? A meta–analysis. Rom. J. Intern. Med., 2013; 51: 152–163. Pais R. Dumitraşcu D.L. Do antioxidants prevent colorectal cancer? A meta–analysis Rom. J. Intern. Med. 2013 51 152 163 Search in Google Scholar

[37] Bjelakovic G., Nagorni A., Nikolova D., Simonetti R.G., Bjelakovic M., Gluud C.: Meta-analysis: Antioxidant supplements for primary and secondary prevention of colorectal adenoma. Aliment. Pharmacol. Ther., 2006; 24: 281–291. Bjelakovic G. Nagorni A. Nikolova D. Simonetti R.G. Bjelakovic M. Gluud C. Meta-analysis: Antioxidant supplements for primary and secondary prevention of colorectal adenoma Aliment. Pharmacol. Ther. 2006 24 281 291 10.1111/j.1365-2036.2006.02970.x Search in Google Scholar

[38] Cadeau C., Fournier A., Mesrine S., Clavel-Chapelon F., Fagherazzi G., Boutron–Ruault M.C.: Vitamin C supplement intake and postmenopausal breast cancer risk: Interaction with dietary vitamin C. Am. J. Clin. Nutr., 2016; 104: 228–234. Cadeau C. Fournier A. Mesrine S. Clavel-Chapelon F. Fagherazzi G. Boutron–Ruault M.C. Vitamin C supplement intake and postmenopausal breast cancer risk: Interaction with dietary vitamin C Am. J. Clin. Nutr. 2016 104 228 234 10.3945/ajcn.115.126326 Search in Google Scholar

[39] Chang Y.J., Myung S.K., Chung S.T., Kim Y., Lee E.H., Jeon Y.J., Park C.H., Seo H.G., Huh B.Y.: Effects of vitamin treatment or supplements with purported antioxidant properties on skin cancer prevention: A meta-analysis of randomized controlled trials. Dermatology, 2011; 223: 36–44. Chang Y.J. Myung S.K. Chung S.T. Kim Y. Lee E.H. Jeon Y.J. Park C.H. Seo H.G. Huh B.Y. Effects of vitamin treatment or supplements with purported antioxidant properties on skin cancer prevention: A meta-analysis of randomized controlled trials Dermatology 2011 223 36 44 10.1159/000329439 Search in Google Scholar

[40] Katta R., Brown D.N.: Diet and skin cancer: The potential role of dietary antioxidants in nonmelanoma skin cancer prevention. J. Skin Cancer, 2015; 2015: 893149. Katta R. Brown D.N. Diet and skin cancer: The potential role of dietary antioxidants in nonmelanoma skin cancer prevention J. Skin Cancer 2015 2015 893149 10.1155/2015/893149 Search in Google Scholar

[41] Jamison J.M., Gilloteaux J., Taper H.S., Calderon P.B., Summers J.L.: Autoschizis: A novel cell death. Biochem. Pharmacol., 2002; 63: 1773–1783. Jamison J.M. Gilloteaux J. Taper H.S. Calderon P.B. Summers J.L. Autoschizis: A novel cell death Biochem. Pharmacol. 2002 63 1773 1783 10.1016/S0006-2952(02)00904-8 Search in Google Scholar

[42] Shenoy N., Bhagat T., Nieves E., Stenson M., Lawson J., Choudhary G.S., Habermann T., Nowakowski G., Singh R., Wu X., et al.: Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells. Blood Cancer J., 2017; 7: e587. Shenoy N. Bhagat T. Nieves E. Stenson M. Lawson J. Choudhary G.S. Habermann T. Nowakowski G. Singh R. Wu X. Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells Blood Cancer J. 2017 7 e587 10.1038/bcj.2017.65554925728731456 Search in Google Scholar

[43] Capone M., Giannarelli D., Mallardo D., Madonna G., Festino L., Grimaldi A.M., Vanella V., Simeone E., Paone M., Palmieri G., et al.: Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab. J. Immunother. Cancer, 2018; 6: 74. Capone M. Giannarelli D. Mallardo D. Madonna G. Festino L. Grimaldi A.M. Vanella V. Simeone E. Paone M. Palmieri G. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab J. Immunother. Cancer 2018 6 74 10.1186/s40425-018-0383-1604871230012216 Search in Google Scholar

[44] McMillan D.C.: Systemic inflammation, nutritional status and survival in patients with cancer. Curr. Opin. Clin. Nutr. Metab. Care, 2009; 12: 223–226.. McMillan D.C. Systemic inflammation, nutritional status and survival in patients with cancer Curr. Opin. Clin. Nutr. Metab. Care 2009 12 223 226 10.1097/MCO.0b013e32832a790219318937 Search in Google Scholar

[45] Kedzierska M., Olas B., Wachowicz B., Glowacki R., Bald E., Czernek U., Szydłowska-Pazera K., Potemski P., Piekarski J., Jeziorski A.: Effects of the commercial extract of aronia on oxidative stress in blood platelets isolated from breast cancer patients after the surgery and various phases of the chemotherapy. Fitoterapia, 2012; 83: 310–317. Kedzierska M. Olas B. Wachowicz B. Glowacki R. Bald E. Czernek U. Szydłowska-Pazera K. Potemski P. Piekarski J. Jeziorski A. Effects of the commercial extract of aronia on oxidative stress in blood platelets isolated from breast cancer patients after the surgery and various phases of the chemotherapy Fitoterapia 2012 83 310 317 10.1016/j.fitote.2011.11.007 Search in Google Scholar

[46] Hoffman F.A.: Micronutrient requirements of cancer patients. Cancer, 1985; 55: 295–300. Hoffman F.A. Micronutrient requirements of cancer patients Cancer 1985 55 295 300 10.1002/1097-0142(19850101)55:1+<295::AID-CNCR2820551315>3.0.CO;2-X Search in Google Scholar

[47] Mayland C.R., Bennett M.I., Allan K.: Vitamin C deficiency in cancer patients. Palliat. Med., 2005; 19: 17–20. Mayland C.R. Bennett M.I. Allan K. Vitamin C deficiency in cancer patients Palliat. Med. 2005 19 17 20 10.1191/0269216305pm970oa Search in Google Scholar

[48] Mikirova N., Casciari J., Riordan N., Hunninghake R.: Clinical experience with intravenous administration of ascorbic acid: Achievable levels in blood for different states of inflammation and disease in cancer patients. J. Transl. Med., 2013; 11: 191. Mikirova N. Casciari J. Riordan N. Hunninghake R. Clinical experience with intravenous administration of ascorbic acid: Achievable levels in blood for different states of inflammation and disease in cancer patients J. Transl. Med. 2013 11 191 10.1186/1479-5876-11-191 Search in Google Scholar

[49] De Loecker W., Janssens J., Bonte J., Taper H.S.: Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. II. Synergism with combined chemotherapy action. Anticancer Res., 1993; 13: 103–106. De Loecker W. Janssens J. Bonte J. Taper H.S. Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. II. Synergism with combined chemotherapy action Anticancer Res. 1993 13 103 106 Search in Google Scholar

[50] Nakagawa K.: Effect of chemotherapy on ascorbate and ascorbyl radical in cerebrospinal fluid and serum of acute lymphoblastic leukemia. Cell. Mol. Biol., 2000, 46: 1375–1381. Nakagawa K. Effect of chemotherapy on ascorbate and ascorbyl radical in cerebrospinal fluid and serum of acute lymphoblastic leukemia Cell. Mol. Biol. 2000 46 1375 1381 Search in Google Scholar

[51] Calderon P.B., Cadrobbi J., Marques C., Hong-Ngoc N., Jamison J.M., Gilloteaux J., Summers J.L., Taper H.S.: Potential therapeutic application of the association of vitamins C and K3 in cancer treatment. Curr. Med. Chem., 2002; 9: 2271–2285. Calderon P.B. Cadrobbi J. Marques C. Hong-Ngoc N. Jamison J.M. Gilloteaux J. Summers J.L. Taper H.S. Potential therapeutic application of the association of vitamins C and K3 in cancer treatment Curr. Med. Chem. 2002 9 2271 2285 10.2174/0929867023368674 Search in Google Scholar

[52] Gilloteaux J., Jamison J.M., Neal D.R., Loukas M., Doberzstyn T., Summers J.L.: Cell damage and death by autoschizis in human bladder (RT4) carcinoma cells resulting from treatment with ascorbate and menadione. Ultrastruct. Pathol., 2010; 34: 140–160. Gilloteaux J. Jamison J.M. Neal D.R. Loukas M. Doberzstyn T. Summers J.L. Cell damage and death by autoschizis in human bladder (RT4) carcinoma cells resulting from treatment with ascorbate and menadione Ultrastruct. Pathol. 2010 34 140 160 10.3109/01913121003662304 Search in Google Scholar

[53] Tareen B., Summers J.L., Jamison J.M., Neal D.R., McGuire K., Gerson L., Diokno A.: A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapy. Int. J. Med. Sci., 2008; 5: 62–67. Tareen B. Summers J.L. Jamison J.M. Neal D.R. McGuire K. Gerson L. Diokno A. A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapy Int. J. Med. Sci. 2008 5 62 67 10.7150/ijms.5.62 Search in Google Scholar

[54] Magrì A., Germano G., Lorenzato A., Lamba S., Chilà R., Montone M., Amodio V., Ceruti T., Sassi F., Arena S., et al.: High-dose vitamin C enhances cancer immunotherapy. Sci. Transl. Med., 2020; 12: eaay8707. Magrì A. Germano G. Lorenzato A. Lamba S. Chilà R. Montone M. Amodio V. Ceruti T. Sassi F. Arena S. High-dose vitamin C enhances cancer immunotherapy Sci. Transl. Med. 2020 12 eaay8707 10.1126/scitranslmed.aay8707 Search in Google Scholar

[55] Rayes R.F., Mouhanna J.G., Nicolau I., Bourdeau F., Giannias B., Rousseau S., Quail D., Walsh L., Sangwan V., Bertos N., et al.: Primary tumors induce neutrophil extracellular traps with targetable metastasis promoting effects. JCI Insight, 2019; 5: e128008. Rayes R.F. Mouhanna J.G. Nicolau I. Bourdeau F. Giannias B. Rousseau S. Quail D. Walsh L. Sangwan V. Bertos N. Primary tumors induce neutrophil extracellular traps with targetable metastasis promoting effects JCI Insight 2019 5 e128008 10.1172/jci.insight.128008677783531343990 Search in Google Scholar

[56] Krakowska M., Debska-Szmich S., Czernek U., Czyzykowski R., Potemski P.: P-032 A complete blood count as a prognostic marker in patients with metastatic colorectal cancer (mCRC). Ann. Oncol., 2016; 27: ii9. Krakowska M. Debska-Szmich S. Czernek U. Czyzykowski R. Potemski P. P-032 A complete blood count as a prognostic marker in patients with metastatic colorectal cancer (mCRC) Ann. Oncol. 2016 27 ii9 10.1093/annonc/mdw199.30 Search in Google Scholar

[57] Hore T.A.: Modulating epigenetic memory through vitamins and TET: Implications for regenerative medicine and cancer treatment. Epigenomics, 2017; 9: 863–871. Hore T.A. Modulating epigenetic memory through vitamins and TET: Implications for regenerative medicine and cancer treatment Epigenomics 2017 9 863 871 10.2217/epi-2017-002128554227 Search in Google Scholar

[58] Guz J., Oliński R.: The role of vitamin C in epigenetic regulation. Postępy Hig. Med. Dośw., 2017; 71: 747–760. Guz J. Oliński R. The role of vitamin C in epigenetic regulation Postępy Hig. Med. Dośw. 2017 71 747 760 10.5604/01.3001.0010.385328894047 Search in Google Scholar

[59] Sant D.W., Mustafi S., Gustafson C.B., Chen J., Slingerland J.M., Wang G.: Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expression. Sci. Rep., 2018; 8: 5306. Sant D.W. Mustafi S. Gustafson C.B. Chen J. Slingerland J.M. Wang G. Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expression Sci. Rep. 2018 8 5306 10.1038/s41598-018-23714-7587177229593282 Search in Google Scholar

[60] Shenoy N., Bhagat T.D., Cheville J., Lohse C., Bhattacharyya S., Tischer A., Machha V., Gordon-Mitchell S., Choudhary G., Wong L.F., et al.: Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma. J. Clin. Invest., 2019; 129: 1612–1625. Shenoy N. Bhagat T.D. Cheville J. Lohse C. Bhattacharyya S. Tischer A. Machha V. Gordon-Mitchell S. Choudhary G. Wong L.F. Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma J. Clin. Invest. 2019 129 1612 1625 10.1172/JCI98747643686230702441 Search in Google Scholar

[61] Luchtel R.A., Bhagat T., Pradhan K., Jacobs W.R. Jr., Levine M., Verma A., Shenoy N.: High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model. Proc. Natl. Acad. Sci. USA, 2020; 117: 1666–1677. Luchtel R.A. Bhagat T. Pradhan K. Jacobs W.R. Jr. Levine M. Verma A. Shenoy N. High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model Proc. Natl. Acad. Sci. USA 2020 117 1666 1677 10.1073/pnas.1908158117698341831911474 Search in Google Scholar

[62] Rubis B., Luczak M.W., Krawic C., Zhitkovich A.: Vitamin C increases DNA breaks and suppresses DNA damage-independent activation of ATM by bleomycin. Free Radic. Biol. Med., 2019; 136: 12–21. Rubis B. Luczak M.W. Krawic C. Zhitkovich A. Vitamin C increases DNA breaks and suppresses DNA damage-independent activation of ATM by bleomycin Free Radic. Biol. Med. 2019 136 12 21 10.1016/j.freeradbiomed.2019.03.026648835930926564 Search in Google Scholar

[63] Buettner G.R., Moseley P.L.: Ascorbate both activates and inactivates bleomycin by free radical generation. Biochemistry, 1992; 31: 9784–9788. Buettner G.R. Moseley P.L. Ascorbate both activates and inactivates bleomycin by free radical generation Biochemistry 1992 31 9784 9788 10.1021/bi00155a0351382593 Search in Google Scholar

[64] Prasad K.N., Hernandez C., Edwards-Prasad J., Nelson J., Borus T., Robinson W.A.: Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-α2b on human melanoma cells in culture by a mixture of vitamins. Nutr. Cancer, 1994; 22: 233–245. Prasad K.N. Hernandez C. Edwards-Prasad J. Nelson J. Borus T. Robinson W.A. Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-α2b on human melanoma cells in culture by a mixture of vitamins Nutr. Cancer 1994 22 233 245 10.1080/016355894095143497877893 Search in Google Scholar

[65] Chiang C.D., Song E.J., Yang V.C., Chao C.C.: Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells. Biochem. J., 1994; 301: 759–764. Chiang C.D. Song E.J. Yang V.C. Chao C.C. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells Biochem. J. 1994 301 759 764 10.1042/bj3010759 Search in Google Scholar

[66] Kurbacher C.M., Wagner U., Kolster B., Andreotti P.E., Krebs D., Bruckner H.W.: Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett., 1996; 103: 183–189. Kurbacher C.M. Wagner U. Kolster B. Andreotti P.E. Krebs D. Bruckner H.W. Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro Cancer Lett. 1996 103 183 189 10.1016/0304-3835(96)04212-7 Search in Google Scholar

[67] Reddy V.G., Khanna N., Singh N.: Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53. Biochem. Biophys. Res. Commun., 2001; 282: 409–415. Reddy V.G. Khanna N. Singh N. Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53 Biochem. Biophys. Res. Commun. 2001 282 409 415 10.1006/bbrc.2001.459311401473 Search in Google Scholar

[68] Bhat S.H., Azmi A.S., Hanif S., Hadi S.M.: Ascorbic acid mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: A putative mechanism for anticancer properties. Int. J. Biochem. Cell Biol., 2006; 38: 2074–2081. Bhat S.H. Azmi A.S. Hanif S. Hadi S.M. Ascorbic acid mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: A putative mechanism for anticancer properties Int. J. Biochem. Cell Biol. 2006 38 2074 2081 10.1016/j.biocel.2006.05.01716861029 Search in Google Scholar

[69] Chen Q., Espey M.G., Sun A.Y., Pooput C., Kirk K.L., Krishna M.C., Khosh D.B., Drisko J., Levine M.: Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc. Natl. Acad. Sci. USA, 2008; 105: 11105–11109. Chen Q. Espey M.G. Sun A.Y. Pooput C. Kirk K.L. Krishna M.C. Khosh D.B. Drisko J. Levine M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice Proc. Natl. Acad. Sci. USA 2008 105 11105 11109 10.1073/pnas.0804226105251628118678913 Search in Google Scholar

[70] Schoenfeld J.D., Sibenaller Z.A., Mapuskar K.A., Wagner B.A., Cramer-Morales K.L., Furqan M., Sandhu S., Carlisle T.L., Smith M.C., Abu Hejleh T., et al.: O²⋅- and H₂O₂-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate. Cancer Cell, 2017; 31: 487–500.e8. Schoenfeld J.D. Sibenaller Z.A. Mapuskar K.A. Wagner B.A. Cramer-Morales K.L. Furqan M. Sandhu S. Carlisle T.L. Smith M.C. Abu Hejleh T. O²⋅- and H₂O₂-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate Cancer Cell 2017 31 487 500.e8 10.1016/j.ccell.2017.07.00828810149 Search in Google Scholar

[71] Carr A.C., Cook J.: Intravenous vitamin C for cancer therapy – identifying the current gaps in our knowledge. Front Physiol., 2018; 9: 1182. Carr A.C. Cook J. Intravenous vitamin C for cancer therapy – identifying the current gaps in our knowledge Front Physiol. 2018 9 1182 10.3389/fphys.2018.01182611550130190680 Search in Google Scholar

[72] Robitaille L., Mamer O.A., Miller W.H. Jr., Levine M., Assouline S., Melnychuk D., Rousseau C., Hoffer L.J.: Oxalic acid excretion after intravenous ascorbic acid administration. Metabolism, 2009; 58: 263–269. Robitaille L. Mamer O.A. Miller W.H. Jr., Levine M. Assouline S. Melnychuk D. Rousseau C. Hoffer L.J. Oxalic acid excretion after intravenous ascorbic acid administration Metabolism 2009 58 263 269 10.1016/j.metabol.2008.09.023348248719154961 Search in Google Scholar

[73] Günes–Bayir A., Kiziltan H.S.: Palliative vitamin C application in patients with radiotherapy-resistant bone metastases: A retrospective study. Nutr. Cancer, 2015; 67, 921–925. Günes–Bayir A. Kiziltan H.S. Palliative vitamin C application in patients with radiotherapy-resistant bone metastases: A retrospective study Nutr. Cancer 2015 67 921 925 10.1080/01635581.2015.105536626168394 Search in Google Scholar

[74] Ma Y., Chapman J., Levine M., Polireddy K., Drisko J., Chen Q.: High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci. Transl. Med., 2014; 6: 222ra18. Ma Y. Chapman J. Levine M. Polireddy K. Drisko J. Chen Q. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy Sci. Transl. Med. 2014 6 222ra18 10.1126/scitranslmed.300715424500406 Search in Google Scholar

[75] Takahashi H., Mizuno H., Yanagisawa A.: High-dose intravenous vitamin C improves quality of life in cancer patients. Personalized Medicine Universe, 2012; 1: 49–53. Takahashi H. Mizuno H. Yanagisawa A. High-dose intravenous vitamin C improves quality of life in cancer patients Personalized Medicine Universe 2012 1 49 53 10.1016/j.pmu.2012.05.008 Search in Google Scholar

[76] Yeom C.H., Jung G.C., Song K.J.: Changes of terminal cancer patients’ health-related quality of life after high dose vitamin C administration. J. Korean Med. Sci., 2007; 22: 7-11. Yeom C.H. Jung G.C. Song K.J. Changes of terminal cancer patients’ health-related quality of life after high dose vitamin C administration J. Korean Med. Sci. 2007 22 7 11 10.3346/jkms.2007.22.1.7269357117297243 Search in Google Scholar

[77] Stephenson C.M., Levin R.D., Spector T., Lis C.G.: Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemother. Pharmacol., 2013; 72: 139–146. Stephenson C.M. Levin R.D. Spector T. Lis C.G. Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer Cancer Chemother. Pharmacol. 2013 72 139 146 10.1007/s00280-013-2179-9369149423670640 Search in Google Scholar

[78] Cameron E., Pauling L.: Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer. Proc. Natl. Acad. Sci. USA, 1978; 75: 4538–4542. Cameron E. Pauling L. Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer Proc. Natl. Acad. Sci. USA 1978 75 4538 4542 10.1073/pnas.75.9.4538336151279931 Search in Google Scholar

[79] Murata A., Morishige F., Yamaguchi H.: Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate. Int. J. Vitam. Nutr. Res. Suppl., 1982; 23: 103–113. Murata A. Morishige F. Yamaguchi H. Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate Int. J. Vitam. Nutr. Res. Suppl. 1982 23 103 113 Search in Google Scholar

[80] Harris H.R., Bergkvist L., Wolk A.: Vitamin C intake and breast cancer mortality in a cohort of Swedish women. Br. J. Cancer, 2013; 109: 257–264. Harris H.R. Bergkvist L. Wolk A. Vitamin C intake and breast cancer mortality in a cohort of Swedish women Br. J. Cancer 2013 109 257 264 10.1038/bjc.2013.269370858323736027 Search in Google Scholar

[81] Vollbracht C., Schneider B., Leendert V., Weiss G., Auerbach L., Beuth J.: Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: Results of a retrospective, multicentre, epidemiological cohort study in Germany. In Vivo, 2011; 25: 983–990. Vollbracht C. Schneider B. Leendert V. Weiss G. Auerbach L. Beuth J. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: Results of a retrospective, multicentre, epidemiological cohort study in Germany In Vivo 2011 25 983 990 Search in Google Scholar

[82] Hoffer L.J., Levine M., Assouline S., Melnychuk D., Padayatty S.J., Rosadiuk K., Rousseau C., Robitaille L., Miller W.H. Jr.: Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann. Oncol., 2008; 19: 1969–1974. Hoffer L.J. Levine M. Assouline S. Melnychuk D. Padayatty S.J. Rosadiuk K. Rousseau C. Robitaille L. Miller W.H. Jr. Phase I clinical trial of i.v. ascorbic acid in advanced malignancy Ann. Oncol. 2008 19 1969 1974 10.1093/annonc/mdn37718544557 Search in Google Scholar

[83] Kiziltan H.S., Bayir A.G., Demirtas M., Meral I., Taspinar O., Eris A.H., Aydin T., Mayadagli A.: Ascorbic-acid treatment for progressive bone metastases after radiotherapy: A pilot study. Altern. Ther. Health Med., 2014; 20: 16–20. Kiziltan H.S. Bayir A.G. Demirtas M. Meral I. Taspinar O. Eris A.H. Aydin T. Mayadagli A. Ascorbic-acid treatment for progressive bone metastases after radiotherapy: A pilot study Altern. Ther. Health Med. 2014 20 16 20 Search in Google Scholar

[84] Polireddy K., Dong R., Reed G., Yu J., Chen P., Williamson S., Violet P.C., Pessetto Z., Godwin A.K., Fan F., et al.: High Dose parenteral ascorbate inhibited pancreatic cancer growth and metastasis: Mechanisms and a phase I/IIa study. Sci. Rep., 2017; 7: 17188. Polireddy K. Dong R. Reed G. Yu J. Chen P. Williamson S. Violet P.C. Pessetto Z. Godwin A.K. Fan F. High Dose parenteral ascorbate inhibited pancreatic cancer growth and metastasis: Mechanisms and a phase I/IIa study Sci. Rep. 2017 7 17188 10.1038/s41598-017-17568-8571936429215048 Search in Google Scholar

[85] Welsh J.L., Wagner B.A., van’t Erve T.J., Zehr P.S., Berg D.J., Halfdanarson T.R., Yee N.S., Bodeker K.L., Du J., Roberts L.J. 2nd, et al.: Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): Results from a phase I clinical trial. Cancer Chemother. Pharmacol., 2013; 71: 765–775. Welsh J.L. Wagner B.A. van’t Erve T.J. Zehr P.S. Berg D.J. Halfdanarson T.R. Yee N.S. Bodeker K.L. Du J. Roberts L.J. 2nd Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): Results from a phase I clinical trial Cancer Chemother. Pharmacol. 2013 71 765 775 10.1007/s00280-013-2070-8358704723381814 Search in Google Scholar

[86] Pinkerton E., Good P., Gibbons K., Hardy J.: An open-label pilot study of oral vitamin C as an opioid-sparing agent in patients with chronic pain secondary to cancer. Support Care Cancer, 2017; 25: 341–343. Pinkerton E. Good P. Gibbons K. Hardy J. An open-label pilot study of oral vitamin C as an opioid-sparing agent in patients with chronic pain secondary to cancer Support Care Cancer 2017 25 341 343 10.1007/s00520-016-3472-z27815713 Search in Google Scholar

[87] Berenson J.R., Yellin O., Woytowitz D., Flam M.S., Cartmell A., Patel R., Duvivier H., Nassir Y., Eades B., Abaya C.D., et al.: Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: An effective and well-tolerated frontline regimen. Eur. J. Haematol., 2009; 82: 433–439. Berenson J.R. Yellin O. Woytowitz D. Flam M.S. Cartmell A. Patel R. Duvivier H. Nassir Y. Eades B. Abaya C.D. Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: An effective and well-tolerated frontline regimen Eur. J. Haematol. 2009 82 433 439 10.1111/j.1600-0609.2009.01244.x19226361 Search in Google Scholar

[88] Riordan H.D., Casciari J.J., González M.J., Riordan N.H., Miranda-Massari J.R., Taylor P., Jackson J.A.: A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. P. R. Health Sci. J., 2005; 24: 269–276. Riordan H.D. Casciari J.J. González M.J. Riordan N.H. Miranda-Massari J.R. Taylor P. Jackson J.A. A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients P. R. Health Sci. J. 2005 24 269 276 Search in Google Scholar

[89] Nielsen T.K., Højgaard M., Andersen J.T., Jørgensen N.R., Zerahn B., Kristensen B., Henriksen T., Lykkesfeldt J., Mikines K.J., Poulsen H.E.: Weekly ascorbic acid infusion in castration-resistant prostate cancer patients: A single-arm phase II trial. Transl. Androl. Urol., 2017; 6: 517–528. Nielsen T.K. Højgaard M. Andersen J.T. Jørgensen N.R. Zerahn B. Kristensen B. Henriksen T. Lykkesfeldt J. Mikines K.J. Poulsen H.E. Weekly ascorbic acid infusion in castration-resistant prostate cancer patients: A single-arm phase II trial Transl. Androl. Urol. 2017 6 517 528 10.21037/tau.2017.04.42 Search in Google Scholar

[90] Zhao H., Zhu H., Huang J., Zhu Y., Hong M., Zhu H., Zhang J., Li S., Yang L., Lian Y., et al.: The synergy of vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia. Leuk. Res., 2018; 66: 1–7. Zhao H. Zhu H. Huang J. Zhu Y. Hong M. Zhu H. Zhang J. Li S. Yang L. Lian Y. The synergy of vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia Leuk. Res. 2018 66 1 7 10.1016/j.leukres.2017.12.009 Search in Google Scholar

[91] Goel S., Agarwal S.B., Mandal A.K., Singhal K., Agarwal T.: Emerging role of ascorbic acid in the management of advanced breast carcinoma as a chemosensitizer. Asian J. Surg., 1999; 22: 333–336. Goel S. Agarwal S.B. Mandal A.K. Singhal K. Agarwal T. Emerging role of ascorbic acid in the management of advanced breast carcinoma as a chemosensitizer Asian J. Surg. 1999 22 333 336 Search in Google Scholar

[92] Jeon Y., Park J.S., Moon S., Yeo J.: Effect of intravenous high dose vitamin C on postoperative pain and morphine use after laparoscopic colectomy: A randomized controlled trial. Pain Res. Manag., 2016; 2016: 9147279. Jeon Y. Park J.S. Moon S. Yeo J. Effect of intravenous high dose vitamin C on postoperative pain and morphine use after laparoscopic colectomy: A randomized controlled trial Pain Res. Manag. 2016 2016 9147279 10.1155/2016/9147279 Search in Google Scholar

[93] Creagan E.T., Moertel C.G., O’Fallon J.R., Schutt A.J., O’Connell M.J., Rubin J., Frytak S:. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N. Engl. J. Med., 1979; 301: 687–690. Creagan E.T. Moertel C.G. O’Fallon J.R. Schutt A.J. O’Connell M.J. Rubin J. Frytak S. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial N. Engl. J. Med. 1979 301 687 690 10.1056/NEJM197909273011303 Search in Google Scholar

[94] Moertel C.G., Fleming T.R., Creagan E.T., Rubin J., O’Connell M.J., Ames M.M.: High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N. Engl. J. Med., 1985; 312: 137-141. Moertel C.G. Fleming T.R. Creagan E.T. Rubin J. O’Connell M.J. Ames M.M. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison N. Engl. J. Med. 1985 312 137 141 10.1056/NEJM198501173120301 Search in Google Scholar

[95] Zemskov V.S., Procopchuk O.L., Susak Y.M., Zemskov S.V., Hodysh Y.Y., Zemskova M.V.: Ukrain (NSC-631570) in the treatment of pancreas cancer. Drugs Exp. Clin. Res., 2000; 26: 179–190. Zemskov V.S. Procopchuk O.L. Susak Y.M. Zemskov S.V. Hodysh Y.Y. Zemskova M.V. Ukrain (NSC-631570) in the treatment of pancreas cancer Drugs Exp. Clin. Res. 2000 26 179 190 Search in Google Scholar

[96] Cameron E., Campbell A.: The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem. Biol. Interact, 1974; 9: 285–315. Cameron E. Campbell A. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer Chem. Biol. Interact 1974 9 285 315 10.1016/0009-2797(74)90019-2 Search in Google Scholar

[97] Carr A.C., McCall C.: The role of vitamin C in the treatment of pain: New insights. J. Transl. Med., 2017; 15: 77. Carr A.C. McCall C. The role of vitamin C in the treatment of pain: New insights J. Transl. Med. 2017 15 77 10.1186/s12967-017-1179-7539156728410599 Search in Google Scholar

[98] Jarosz M., Rychlik E., Stoś K., Charzewska J. (eds.): Normy żywienia dla populacji Polski i ich zastosowanie. Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny, Warszawa 2020. Jarosz M. Rychlik E. Stoś K. Charzewska J. Normy żywienia dla populacji Polski i ich zastosowanie Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny Warszawa 2020 Search in Google Scholar

[99] Lykkesfeldt J., Poulsen H.E.: Is vitamin C supplementation beneficial? Lessons learned from randomised controlled trials. Br. J. Nutr., 2010; 103: 1251–1259. Lykkesfeldt J. Poulsen H.E. Is vitamin C supplementation beneficial? Lessons learned from randomised controlled trials Br. J. Nutr. 2010 103 1251 1259 10.1017/S000711450999322920003627 Search in Google Scholar